多发性大动脉炎的临床诊疗进展
Progress in Clinical Diagnosis and Treatment of Multiple Aortitis
DOI: 10.12677/ACM.2024.142403, PDF,   
作者: 苏丽娅·拜合提亚, 罗 莉*：新疆医科大学第一附属医院风湿免疫科，新疆 乌鲁木齐
关键词: 多发性大动脉炎；病因；诊断；治疗；Multiple Arteritis； Etiology； Diagnosis； Treatment
摘要: 多发性大动脉炎(Takayasu arteritis, TA)是一种主要影响主动脉及其主要分支的非特异性炎性病变。其病因尚不明确，可能与细菌、病毒感染、遗传因素以及免疫异常等有关。故诊断及治疗方式不完全相同，其临床诊断及诊疗方式在不断更新中，因此，本文将对TA的临床特点、诊断和治疗进展进行详细综述。
Abstract: Takayasu arteritis (TA) is a non-specific inflammatory disease that mainly affects the aorta and its major branches. Its etiology is not clear, and may be related to bacterial and viral infections, genetic factors and immune abnormalities. Therefore, the diagnosis and treatment methods are not exactly the same, and its clinical diagnosis and treatment methods are constantly updated. Therefore, this paper will review the clinical characteristics, diagnosis and treatment progress of TA in detail.
文章引用：苏丽娅·拜合提亚, 罗莉. 多发性大动脉炎的临床诊疗进展[J]. 临床医学进展, 2024, 14(2): 2852-2858. https://doi.org/10.12677/ACM.2024.142403

参考文献

[1] Wen, X.T., Song, G., Hu, C.J., et al. (2020) Identification of Novel Serological Autoantibodies in Takayasu Arteritis Pa-tients Using HuProt Arrays. Molecular & Cellular Proteomics, 20, Article ID: 100036. [Google Scholar] [CrossRef] 
[2] Espinoza, J., Suzue, A. and Itaru, M. (2018) New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory. Pathogens, 7, Article No. 73. [Google Scholar] [CrossRef] [PubMed]
[3] Villon, M.L.F.Z., de la Rocha, J.A.L. and Espinoza, L.R. (2020) Takayasu Arteritis: Recent Developments. Current Rheumatology Reports, 21, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[4] Kerr, G.S. (1994) Takayasu Arteritis. Annals of Internal Medicine, 120, 919-929. [Google Scholar] [CrossRef] [PubMed]
[5] Bicakcigil, M., Aksu, K., Kamali, S., et al. (2009) Takayasu’s Arteritis in Turkey—Clinical and Angiographic Features of 248 Patients. Clinical & Experimental Rheumatology, 27, S59-S64.
[6] Kaichiro, I. (1988) Diagnostic Approach and Proposed Criteria for the Clinical Diag-nosis of Takayasu’s Arteriopathy. Journal of the American College of Cardiology, 12, 964-972. [Google Scholar] [CrossRef] [PubMed]
[7] Bloch, D.A., Michel, B.A., Hunder, G.G., et al. (2010) The American College of Rheumatology 1990 Criteria for the Classification of Vasculitis: Patients and Methods. Arthritis & Rheumatism, 33, 1068-1073.
[8] Grayson, P.C., Ponte, C., Suppiah, R., et al. (2022) 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis. Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research, 81, 1654-1660. [Google Scholar] [CrossRef] [PubMed]
[9] 邹玉宝, 宋雷, 蒋雄京. 大动脉炎诊断标准研究进展[J]. 中国循环杂志, 2017, 32(1): 90-92. [Google Scholar] [CrossRef] 
[10] 吴思凡, 马莉莉, 陈慧勇, 等. 不同诊断/分类标准对大动脉炎诊断的价值研究[J]. 中华风湿病学杂志, 2021, 25(11): 727-732. [Google Scholar] [CrossRef] 
[11] Keser, G., Direskeneli, H. and Aksu, K. (2014) Management of Takayasu Arteritis: A Systematic Review. Rheumatology, 53, 793-801. [Google Scholar] [CrossRef] [PubMed]
[12] Sivakumar, M.R., Misra, R.N. and Bacon, P.A. (2005) OP14. The Indian Perspective of Takayasu Arteritis and Development of a Disease Extent Index (DEI.TAK) to Assess Takaya-su Arteritis. Rheumatology, 44, Iii6-Iii7. [Google Scholar] [CrossRef] 
[13] Misra, R., Danda, D., Rajappa, S.M., et al. (2013) Development and Initial Validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology, 52, 1795-1801. [Google Scholar] [CrossRef] [PubMed]
[14] Li, J., Wang, Y., Wang, Y., et al. (2020) Association between Acute Phase Reactants, Interleukin-6, Tumor Necrosis Factor-α, and Disease Activity in Takayasu’s Arteritis Patients. Arthritis Research & Therapy, 22, Article No. 285. [Google Scholar] [CrossRef] [PubMed]
[15] Svensson, C., Eriksson, P. and Zachrisson, H. (2020) Vascular Ultrasound for Monitoring of Inflammatory Activity in Takayasu Arteritis. Clinical Physiology and Functional Imaging, 40, 37-45. [Google Scholar] [CrossRef] [PubMed]
[16] Mattay, R.R., Saucedo, J.F., Lehman, V.T., et al. (2021) Current Clinical Applications of Intracranial Vessel Wall MR Imaging. Seminars in Ultrasound CT and MRI, 42, 463-473. [Google Scholar] [CrossRef] [PubMed]
[17] Song, J.W., Obusez, E.C., Raymond, S.B., et al. (2019) Vessel Wall MRI Added to MR Angiography in the Evaluation of Suspected Vasculopathies: Vessel Wall MRI with MRA. Journal of Neuroimaging, 29, 454-457. [Google Scholar] [CrossRef] [PubMed]
[18] Dejaco, C., Ramiro, S., Duftner, C., et al. (2018) EULAR Recommenda-tions for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice. Annals of the Rheumatic Diseases, 76, 24. [Google Scholar] [CrossRef] 
[19] Kang, F., Han, Q., Zhou, X., et al. (2020) Performance of the PET Vascular Activity Score (PETVAS) for Qualitative and Quantitative Assessment of Inflammatory Activity in Takayasu’s Arteritis Patients. European Journal of Nuclear Medicine and Molecular Imaging, 47, 3107-3117. [Google Scholar] [CrossRef] [PubMed]
[20] Schfer, V.S., Jin, L. and Schmidt, W.A. (2020) Imaging for Di-agnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides. Current Rheumatology Reports, 22, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
[21] Hellmich, B., Gueda, A.F., Monti, S., et al. (2020) Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future. Current Rheumatology Reports, 22, Arti-cle No. 84. [Google Scholar] [CrossRef] [PubMed]
[22] Seyahi, E., Ugurlu, S., Cumali, R., et al. (2006) Ath-erosclerosis in Takayasu Arteritis. Annals of the Rheumatic Diseases, 65, 1202-1207. [Google Scholar] [CrossRef] [PubMed]
[23] Numano, F., Shimokado, K., Kishi, Y., et al. (1982) Changes in the Plasma Levels of Thromboxane B2 and Cyclic Nucleotides in Patients with Takayasu Disease. Japanese Circulation Journal, 46, 16-20. [Google Scholar] [CrossRef] [PubMed]
[24] Akazawa, H., Ikeda, U., Yamamoto, K., et al. (1996) Hypercoagulable State in Patients with Takayasu’s Arteritis. Thrombosis and Haemostasis, 75, 712-716. [Google Scholar] [CrossRef] 
[25] Wu, S., Kong, X., Cui, X., et al. (2023) Effectiveness and Safety of Tocilizumab in Patients with Refractory or Severe Takayasu’s Arteritis: A Prospective Cohort Study in a Chinese Popu-lation. Joint Bone Spine, 88, Article ID: 105186. [Google Scholar] [CrossRef] [PubMed]
[26] Cui, X., Kong, X., Chen, R., Ma, L. and Jiang, L. (2020) The Potential Role of Leflunomide in Inhibiting Vascular Fibrosis by Down-Regulating Type-II Macrophages in Takayasu’s Arteritis. Clinical and Experimental Rheumatology, 38, S69-S78.
[27] Schmidt, J., Kermani, T.A., Bacani, A.K., et al. (2012) Tumor Necrosis Factor Inhibitors in Patients with Takayasu Arteritis: Experience from a Referral Center with Long-Term Follow-Up. Arthritis Care & Research, 64, 1079-1083. [Google Scholar] [CrossRef] [PubMed]
[28] Hoffman, G.S., Merkel, P.A., Brasington, R.D., et al. (2004) Anti-Tumor Necrosis Factor Therapy in Patients with Difficult to Treat Takayasu Arteritis. Arthritis & Rheumatism, 50, 2296-2304. [Google Scholar] [CrossRef] [PubMed]
[29] Molloy, E.S., Langford, C.A., Clark, T.M., et al. (2008) Anti-Tumour Ne-crosis Factor Therapy in Patients with Refractory Takayasu Arteritis: Long-Term Follow-Up. Annals of the Rheumatic Diseases, 67, 1567-1569. [Google Scholar] [CrossRef] [PubMed]
[30] Arita, Y., Nakaoka, Y., Eda, Y., et al. (2020) Perioperative Man-agement of Takayasu Arteritis for Cardiac Surgery in a Patient Treated with Tocilizumab. JACC Case Reports, 2, 2363-2367. [Google Scholar] [CrossRef] [PubMed]
[31] 邢月浩, 郭建明, 谷涌泉. 多发性大动脉炎血管内介入治疗和开放手术现状[J]. 介入放射学杂志, 2019, 28(6): 599-602.

为你推荐